| Date Filed | Type | Description |
| 01/04/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,093 restricted stock units
@ $0 |
|
| 12/02/2020 |
3
| MITCHELL DEAN J (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2020 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 6,635 shares
@ $0
Granted 6,000 options to buy
@ $30.14, valued at
$180.8k
|
|
| 04/02/2020 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,958 restricted stock units
@ $0 |
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 6,221 restricted stock units
@ $0 |
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,385 shares
@ $0
Granted 6,000 options to buy
@ $23.85, valued at
$143.1k
|
|
| 04/01/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 4,981 restricted stock units
@ $0 |
|
| 03/26/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on INTREXON CORP|
Txns:
| Exercised 7,911 restricted stock units
@ $0 |
|
| 03/12/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on INTREXON CORP|
Txns:
| Granted 11,166 shares
@ $5.06, valued at
$56.5k
Granted 24,703 restricted stock units
@ $0
Granted 42,450 options to buy
@ $5.06, valued at
$214.8k
Exercised 8,906 options to buy
@ $3.17, valued at
$28.2k
|
|
| 01/02/2019 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 2,812 restricted stock units
@ $0 |
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2018 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 1,387 restricted stock units
@ $0 |
|
| 06/22/2018 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 4,000 restricted stock units
@ $0
Granted 18,000 options to buy
@ $11.21, valued at
$201.8k
|
|
| 05/03/2018 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,186 shares
@ $0
Granted 6,000 options to buy
@ $24.43, valued at
$146.6k
|
|
| 04/02/2018 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 1,283 restricted stock units
@ $0 |
|
| 03/29/2018 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on INTREXON CORP|
Txns:
| Granted 3,575 shares
@ $15.8, valued at
$56.5k
Granted 7,911 restricted stock units
@ $0
Granted 14,246 options to buy
@ $15.8, valued at
$225.1k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on INTREXON CORP|
Txns:
| Bought 5,000 shares
@ $18.3279, valued at
$91.6k
|
|
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/18/2017 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on INTREXON CORP |
|